Amprius Technologies Inc

AMPX remains entrenched in a Stage 4 downtrend with price below all major moving averages, reinforcing a bearish medium-term bias. Short-term momentum continues to reject rallies into the declining EMAs without clear oversold exhaustion, supporting selling now on failed recoveries. No active reversal patterns are present, and negative valuation metrics and high short interest underscore persistent downside pressure.

• ↑Q2 revenue hit $34M, up 137% YoY and 19% sequentially
• ↑Full-year sales forecast raised to ≥$140M after $24M European contract
• ↓Negative earnings yield and book-to-price suggest overvaluation